Prelude Therapeutics Inc SEC filings PRLD
Prelude Therapeutics Inc has 389 filings in SEC EDGAR's recent list, going back to Jul 11, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 16, 2025 | — |
| CORRESP | Letter to the SEC | Dec 15, 2025 | — |
| EFFECT | Filing | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | Jun 6, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2024 | — |
| EFFECT | Filing | May 8, 2024 | — |
| CORRESP | Letter to the SEC | May 6, 2024 | — |
| CORRESP | Letter to the SEC | May 3, 2024 | — |
| CORRESP | Letter to the SEC | May 1, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 21, 2024 | — |
| EFFECT | Filing | Nov 24, 2021 | — |
| CORRESP | Letter to the SEC | Nov 22, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2021 | — |
| EFFECT | Filing | Jan 6, 2021 | — |
| CORRESP | Letter to the SEC | Jan 4, 2021 | — |
| CORRESP | Letter to the SEC | Jan 4, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2020 | — |
| DRS | Filing | Dec 21, 2020 | — |
| EFFECT | Filing | Sep 24, 2020 | — |
| CERT | Filing | Sep 24, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| 8-A12B | Filing | Sep 16, 2020 | — |
| CORRESP | Letter to the SEC | Sep 16, 2020 | — |
| CORRESP | Letter to the SEC | Sep 9, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2020 | — |
| D | Filing | Aug 28, 2020 | — |
| DRSLTR | Filing | Aug 26, 2020 | — |
| DRS/A | Filing | Aug 26, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2020 | — |
| DRS | Filing | Jul 23, 2020 | — |
| D | Filing | Jun 17, 2019 | — |
| D/A | Filing | Aug 17, 2018 | — |
| D | Filing | Oct 20, 2017 | — |
| D | Filing | Jul 11, 2016 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRLD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmington, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1678660
- Former names
- Prelude Therapeutics Inc. (until Oct 20, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.